Click here to visit Vernalis plc
Page 5 of 6
Vernalis plc (LSE: VER) today announces its audited financial results for the year ended 30 June 2017, following the year-end trading update published on 18 July 2017.
For more information on Vernalis, click below to download a copy of our fact sheet
T: 1-484-913-0700 F: 1-610-651 5976Contact informationMaps and directionsContact form
To report SUSPECTED ADVERSE REACTIONS, contact Vernalis Therapeutics, Inc. at 1-855-705-9546 and email@example.com or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch